Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation (Prevention of Stroke)”

120 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 120 results

Not applicableActive Not RecruitingNCT07194811
What this trial is testing

Stroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke Recurrence

Who this might be right for
Cryptogenic StrokeAtrial FibrillationImplantable Cardiac Monitor+4 more
University Hospital, Akershus 1,400
Not applicableStudy completedNCT04322474
What this trial is testing

Russian National Registry of LAAO

Who this might be right for
Atrial Fibrillation
National Research Center for Preventive Medicine 200
Not applicableStudy completedNCT03374540
What this trial is testing

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Who this might be right for
Nonvalvular Atrial Fibrillation
Bayer 78,517
Post-approval studies (Phase 4)Study completedNCT01288352
What this trial is testing

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial

Who this might be right for
Atrial FibrillationStroke
Atrial Fibrillation Network 2,789
Not applicableStudy completedNCT05321810
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 193,565
Post-approval studies (Phase 4)UnknownNCT01461434
What this trial is testing

Graz Study on the Risk of Atrial Fibrillation

Who this might be right for
Atrial FibrillationHypertensionDiabetes+2 more
Medical University of Graz 82
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Not applicableStudy completedNCT03867227
What this trial is testing

Non-pharmacological Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
National Research Center for Preventive Medicine 300
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Large-scale testing (Phase 3)Study completedNCT00262600
What this trial is testing

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Who this might be right for
Atrial FibrillationStroke
Boehringer Ingelheim 18,113
Not applicableStudy completedNCT01606995
What this trial is testing

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 6,784
Not applicableStudy completedNCT01947998
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 50,299
Not applicableLooking for participantsNCT04559243
What this trial is testing

Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events

Who this might be right for
Non-valvular Atrial FibrillationEmbolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd. 579
Not applicableStudy completedNCT02344901
What this trial is testing

ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

Who this might be right for
Thrombotic StrokeAtrial Fibrillation and Flutter
Muğla Sıtkı Koçman University 6,273
Not applicableStudy completedNCT02273700
What this trial is testing

Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention

Who this might be right for
Atrial Fibrillation
Centre Hospitalier Universitaire de Nīmes 5
Not applicableStudy completedNCT03119116
What this trial is testing

Use of Direct Oral Anticoagulants in UK

Who this might be right for
Stroke
Bayer 31,336
Large-scale testing (Phase 3)Study completedNCT03996772
What this trial is testing

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Imperial College London 319
Not applicableLooking for participantsNCT06922695
What this trial is testing

Responding to AF: Pill-in-Pocket Anticoagulation Guided by Automated Monitoring and Alerts

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)
Oxford University Hospitals NHS Trust 50
Not applicableStudy completedNCT02956343
What this trial is testing

SmartWATCHes for Detection of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University Hospital, Basel, Switzerland 651
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Load More Results